Los Angeles, CA , Aug. 08, 2024 (GLOBE NEWSWIRE) -- Los Angeles, August 8, 2024 — Kronos Advanced Technologies, Inc. (OTC: KNOS) is pleased to announce that the interests in DogeSPAC LLC, a previously spun-off entity, are now eligible for removal of restricted legend from their unit certificates. This significant milestone comes after the required holding period has elapsed in accordance with SEC rules.
Effective immediately, Broker Dealers’ Clearing Houses holding DogeSPAC LLC certificates for their clients may request the removal of any restriction legends. This development marks a pivotal moment for our shareholders, enhancing the potential for liquidity and providing greater flexibility in managing their investments should a market develop for DogeSPAC LLC units.
DogeSPAC LLC was spun-off from Kronos, as announced on June 22, 2021. Kronos distributed DogeSPAC LLC units to its shareholders on August 25, 2021, with each shareholder receiving one unit per share held as of the record date of June 15, 2021. Kronos retains a 20% ownership stake in DogeSPAC LLC. The minority owners of DogeSPAC LLC have now met the necessary requirements for this free trading status, signifying compliance with all relevant SEC regulations. Currently the units of DogeSPAC LLC are not listed nor do they trade on any market.
DogeSPAC LLC is considering merging with an existing public company and/or allowing the LLC interests to be converted into crypto LLC interests for trading on a decentralized exchange. The final decision regarding which blockchain—whether Solana, Binance, or Ethereum—will be made soon. DogeSPAC LLC owners are encouraged to make recommendations as to which blockchain they would prefer to see their LLC interests held.
For more information and updates on this development, please visit www.DogeSPAC.com
For further inquiries, please contact:
Investor Relations
DogeSPAC LLC/ Kronos Advanced Technologies Inc
Phone: (680)STOCK-TA (680)786-2582 accepts text messages only
Email: info@DogeSPAC.com
About Kronos Advanced Technologies Inc.
The Company was initially founded in 2002 and funded by the U.S. military to develop electrostatic air movers. Kronos Advanced Technologies Inc. filed about 50 patent applications in the past and had total of 25 issued patents. These patents encompass a range of technologies primarily focused on air movement, filtration, and purification systems. The company, known for its innovations in air movement and filtration technologies, has an extensive patent portfolio that reflects its focus on advanced consumer electronics and medical-grade air purification products. Eventually, the Company moved into the consumer air purification business. It began operations as a product development company that invented and significantly changed how air is moved, filtered, and sterilized. Historically, Kronos has focused on developing, marketing, and selling the Company's proprietary air movement and purification technology. Serving the Indoor Air Quality (IAQ) market, Kronos technology uses state-of-the-art high-voltage patented processes without the use of traditional porous HEPA filters. Kronos-based products move air silently, filter, sterilize, and purify the air while dramatically reducing energy consumption to half of a 60-watt light bulb.
Kronos devices can be variable in shape or size and, therefore, have the potential to be scaled down for air purification in cars or scaled up in size for industrial and hazardous gas destruction. The technology is currently being implemented in multiple standalone products for businesses, homes, and vehicles of all types -to move, sterilize and filter air, including removing allergens down to 14.6 nanometers, passing through our patented technology -replacing expensive outdated passive HEPA and other filtration type systems. There are broad ranges of additional markets for standalone and embedded Kronos CORE technology-based devices. Examples of immediately addressable markets include schools, universities, healthcare facilities, operating rooms, manufacturing clean rooms, and the cabins of automobiles and commercial aircraft.
Kronos published research about the effectiveness of Kronos Patented technology on air disinfection n (e.g., microorganism destruction) by demonstrating the high efficacy of Kronos® Technology-based air purifiers in capturing and destruction of various types of microorganisms (including Corona Viruses) in different environmental settings back in 2008. Results of this research showed that Electrostatic Air Filtration and Purification systems based on Kronos technology demonstrated high capturing and destruction efficiency for different types of microorganisms, bacteria, and viruses, and can be successfully used for disinfection of air in real word environmental settings, including hospital facilities both with and without the presence of people.
BusinessWeek called Kronos air purifiers "VIRUS KILLER" in 2005.
Kronos is the first publicly traded company that accepts Dogecoin as a form of payment for its products, as well as other cryptocurrencies.
The Company is planning to file additional patents to improve its existing technology as well as enter into new market segments but will continue to market air purifiers and other consumer products. The Company is an exclusive distributor and licensee of the latest generation of air purifiers based on the Company's CORE technologies. The Company markets its products as Airdog® and KRONOS® brands. All Kronos products come with Kronos Promise ™ -Your Satisfaction is Guaranteed!
Since our inception in 2002, Kronos Advanced Technologies has been at the forefront of innovation, revolutionizing the way air is moved, filtered, and sterilized. Our patented technology has been instrumental in various sectors, including indoor air quality, automotive, and healthcare.
Kronos Advanced Technologies, Inc. (OTC MARKETS: KNOS) announced in 2023 that the U.S. Food and Drug Administration (FDA) had granted 510(k) clearance to the company’s manufacturer, classifying its Model 5 Air Purifier as a Class II Medical Device. This clearance is a significant achievement, validating Kronos' patented High Voltage Field air disinfection technology, proven to eliminate 99.9% of harmful airborne particles, including allergens, bacteria, fungi, and viruses like COVID-19.
With FDA clearance, Kronos can now deploy its medical-grade air purification and air disinfection technology in hospitals, home health-care settings, schools, healthcare facilities, businesses, hotels, and government agencies. This milestone underscores Kronos' commitment to improving Indoor Air Quality (IAQ) and providing healthier and safer air environments.
As we embark on this new chapter with Kronos Advanced Technologies Inc., we remain committed to our mission of enhancing the health and well-being of individuals worldwide. We are proud to be pioneers in accepting cryptocurrencies, including Dogecoin,and Shiba Inu coins as a form of payment for our products, reflecting our dedication to embracing emerging technologies.
Our dedication to customer satisfaction remains unwavering, and we invite you to explore our products and offerings through our online shopping portal and social media channels.
The Company is an exclusive distributor and licensee of the latest generation of air purifiers based on the Company's CORE technologies.
The Company markets its products as Airdog® and KRONOS® brands. All Kronos products come with Kronos Promise ™ -Your Satisfaction is Guaranteed!
Company offices are located in Parkersburg, West Virginia.
Shopping portal: www.KronosAIR.com
TikTok shop https://www.tiktok.com/@kronosair
Follow KNOS on Twitter: https://twitter.com/kronosati
Follow KNOS on Facebook: https://www.facebook.com/kronosati
Follow KNOS on Instagram: https://www.instagram.com/kronos_ati/
Follow KNOS on Youtube: https://www.youtube.com/@KronosAdvancedTechnologies
Follow KNOS on Reddit: https://www.reddit.com/user/Kronos_ATI
Follow KNOS on LinkedIn: https://www.linkedin.com/company/kronos-advanced-techngologies-inc
Contact us via info@kronosati.co or visit https://www.kronosAIR.com
Disclaimer
This filing does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or any other product or service by Kronos Advanced Technologies Inc or any other third party regardless of whether such security, product, or service is referenced in this press release. Furthermore, nothing in this press release is intended to provide tax, legal, or investment advice, and nothing in it should be construed as a recommendation to buy, sell, or hold any investment or security or to engage in any investment strategy or transaction. Kronos Advanced Technologies does not represent that the securities, products, or services discussed in this press release are suitable for any particular investor. You are solely responsible for determining whether any investment, investment strategy, security, or related transaction is appropriate for you based on your personal investment objectives, financial circumstances, and risk tolerance. You should consult your business advisor, attorney, and/or tax and accounting advisor regarding your specific business, legal, or tax situation.
Social Media Disclaimer and Forward-Looking Statements.
Kronos Advanced Technologies investors and others should note that we announce material information to the public about the Company through various means, including our website (https://www.kronosati.co/investors), press releases, OTCmarkets filings, public conference calls, via our corporate Social Media accounts, listed above. We encourage our investors and others to monitor and review the information we make public in these locations, as such information could be deemed to be material information. Please note that this list may be updated from time to time. Certain statements contained in this press release may constitute "forward-looking statements." Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the OTC Markets at OTCMarkets.com. In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company's ability to raise capital on acceptable terms, if at all, the Company's successful development of its products and the integration into its existing products and the commercial acceptance of the Company's products. The forward-looking statements included in this press release represent the Company's views as of the date of this press release, and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release.
SOURCE: KRONOS ADVANCED TECHNOLOGIES, Inc
Tel: (716) OTC-KNOS (716) 682-5667 accepts text messages only
